Pre-transplant FDG-PET-based survival model in relapsed and refractory Hodgkin's lymphoma: outcome after high-dose chemotherapy and auto-SCT.
about
Prognostic value of pretransplant FDG-PET in refractory/relapsed Hodgkin lymphoma treated with autologous stem cell transplantation: systematic review and meta-analysisPrevalence of menstrual cycles and outcome of 50 pregnancies after high-dose chemotherapy and auto-SCT in non-Hodgkin and Hodgkin lymphoma patients younger than 40 yearsA prognostic model predicting autologous transplantation outcomes in children, adolescents and young adults with Hodgkin lymphoma.Improved outcome of patients with relapsed/refractory Hodgkin lymphoma with a new fotemustine-based high-dose chemotherapy regimen.Managing Hodgkin lymphoma relapsing after autologous hematopoietic cell transplantation: a not-so-good cancer after all!Recurrent Hodgkin lymphoma: toward a new definition of candidates for autologous stem cell transplant in the era of positron emission tomography scan and novel agents.Brentuximab vedotin for the treatment of Hodgkin's lymphoma.Where Do the New Drugs Fit in for Relapsed/Refractory Hodgkin Lymphoma?Risk factors predicting outcomes for primary refractory hodgkin lymphoma patients treated with salvage chemotherapy and autologous stem cell transplantationHigh-dose chemotherapy and autologous stem cell transplantation for relapsed or refractory nodular lymphocyte predominant Hodgkin lymphoma.High dose chemotherapy and autologous stem cell transplantation in nodular lymphocyte-predominant Hodgkin lymphoma: A retrospective study by the European society for blood and marrow transplantation-lymphoma working party.Outcome analysis of high-dose chemotherapy and autologous stem cell transplantation in adolescent and young adults with relapsed or refractory Hodgkin lymphoma.Translation and validation of the Functional Assessment of Cancer Therapy-Bone Marrow Transplant (FACT-BMT) version 4 quality of life instrument into Arabic language.
P2860
Q26765151-43FE147A-AE18-47B9-A7B8-95E5845AD6E6Q33586692-D6897FE2-E4FE-4654-AA0A-8153EA7D88D2Q36248964-3416CB37-035C-410C-B6FB-F8D0CF92290AQ37316657-E78E712B-D468-4B7E-A208-FCE5357BB6FFQ38179975-2D7BD55E-D1FD-4928-B306-C55FBD7F1A44Q38264356-A1F3EE89-4916-4B94-ACEF-1C71405A5912Q38476250-50569425-5A7F-4D5B-B0BF-B76614C5E116Q39294879-59627E46-8CA6-4DD8-8061-E1BCE35F9AA1Q40513698-578F38A7-B880-4A3A-A1EE-BBA8AD4BEC6BQ41220681-779D6921-5112-47E6-B974-23C47E803F59Q47877461-06D7C090-B4A9-4344-AFBF-5E3F13C83225Q50880574-9248234C-7505-43EB-AFC1-D2E2AB4F80C6Q52660194-3BCACD78-93C3-45B5-8D4C-4BDA6950DD4F
P2860
Pre-transplant FDG-PET-based survival model in relapsed and refractory Hodgkin's lymphoma: outcome after high-dose chemotherapy and auto-SCT.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
Pre-transplant FDG-PET-based s ...... ose chemotherapy and auto-SCT.
@en
Pre-transplant FDG-PET-based s ...... ose chemotherapy and auto-SCT.
@nl
type
label
Pre-transplant FDG-PET-based s ...... ose chemotherapy and auto-SCT.
@en
Pre-transplant FDG-PET-based s ...... ose chemotherapy and auto-SCT.
@nl
prefLabel
Pre-transplant FDG-PET-based s ...... ose chemotherapy and auto-SCT.
@en
Pre-transplant FDG-PET-based s ...... ose chemotherapy and auto-SCT.
@nl
P2093
P2860
P356
P1476
Pre-transplant FDG-PET-based s ...... ose chemotherapy and auto-SCT.
@en
P2093
A Eltigani
A S Al-Sugair
I Maghfoor
M Abdelsalam
M Abouzied
M Nabil-Ahmed
P2860
P2888
P304
P356
10.1038/BMT.2013.88
P407
P577
2013-06-10T00:00:00Z